Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-07-18Endurance Training in Severely Disabled Patients With MS - a Feasibility Study
-
CLINICAL_TRIALS study record update · 2013-07-01A Phase II, Multicenter, Randomized, Double Blind, Placebo Controlled, Safety, Tolerability and Efficacy Study of Add-on Cladribine Tablet Therapy With Interferon-beta (IFN-β) Treatment in Multiple Sclerosis Subjects With Active Disease
-
CLINICAL_TRIALS study record update · 2013-06-27Safety and Neuroprotective Effects of Polyphenon E in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2013-06-26A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2013-06-25Evaluation of Risk Factors for Premature Discontinuation of Injection Treatment With Betaferon in Patients With Relapsing Forms of Multiple Sclerosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-06-21Longitudinal (Weekly) Follow-up of Active Plaques in Multiple Sclerosis With 3 Teslas Multi-modality MRI Using Diffusion, Perfusion, Venography and Proton Spectroscopy
-
CLINICAL_TRIALS study record update · 2013-06-19A Randomized, Open-label, Parallel-Group Multicenter Study to Determine the Safety/Efficacy of Mycophenolate Mofetil in Mono & Combination Therapy With Interferon Beta 1a in Patients With Relapsing Remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2013-06-14Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in a Natalizumab Treated Population With Active Control Assessment
-
CLINICAL_TRIALS study record update · 2013-06-11Improving New Learning in Multiple Sclerosis: A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2013-06-11Functional and Physiological Responses to Lokomat Therapy (Pilot Study)
-
CLINICAL_TRIALS study record update · 2013-05-30Retrospective Cohort Study of Rebif® Use in Pediatric MS Patients
-
CLINICAL_TRIALS study record update · 2013-05-17Investigation of Grey Matter Pathology Using Ultra High Field (7T) MRI Scanner
-
CLINICAL_TRIALS study record update · 2013-05-16MEsenchymal StEm Cells for Multiple Sclerosis (MESEMS) Phase I-II Clinical Trial With Autologous Mesenchymal Stem Cells (MSCs) for the Therapy of Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2013-05-15Apraxia-specific Occupational Therapy in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2013-05-07A Prospective, Observational, Single-blinded, Longitudinal Study of Natalizumab Effect on Brain Atrophy and Disability in Multiple Sclerosis Patients Over 5 Years.
-
CLINICAL_TRIALS study record update · 2013-05-03Whole Body Vibration Therapy in Participants With MS Related Balance Deficits
-
CLINICAL_TRIALS study record update · 2013-05-03A Twenty-four Week, Two Arm, Pilot Trial to Evaluate Remyelination/ Demyelination, Gray Matter Volume and Iron Deposition in the Central Nervous System (CNS) and Immune Status of Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) Treated With Rebif® 44 mcg Subcutaneously (sc) Three Times a Week (Tiw) Compared to a Healthy Control Group
-
CLINICAL_TRIALS study record update · 2013-04-22Modeling and Treating the Pathophysiology of Demyelination in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2013-04-22A One-Year Prospective, Randomized, Placebo-Controlled, Double-Blind, Phase II/III Safety Trial of Combination Therapy With IFN Beta-1a (Avonex) and Mycophenolate Mofetil (Cellcept) in Early Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2013-04-18Continuous Positive Airway Pressure for Fatigue Treatment in Patients With Multiple Sclerosis and Obstructive Sleep Apnea
-
CLINICAL_TRIALS study record update · 2013-04-09CCRC: The Analgesic Effect of Vaporized Cannabis on Neuropathic Pain
-
CLINICAL_TRIALS study record update · 2013-03-25A Prospective, Observational, Single-blinded, Longitudinal MRI Study of Effect of Glatiramer Acetate on Iron Deposition in Patients With Relapsing-remitting Multiple Sclerosis Over 24 Months
-
CLINICAL_TRIALS study record update · 2013-03-11The Effects of Attention Retraining on Cognitive Performance, QoL and Perceived Cognitive Impairment in MS - a Single Blind, Randomized, Controlled Study
-
CLINICAL_TRIALS study record update · 2013-02-28Effectiveness of a Teleconference Delivered Fatigue Management Program for People With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2013-02-26Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide Treatment and Using a Population of Patients With Multiple Sclerosis as a Reference